KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,800,946 | -53.2% | 117,103 | -39.9% | 0.01% | -57.1% |
| Q2 2023 | $42,280,979 | +1467480.0% | 194,978 | +1230.0% | 0.02% | +950.0% |
| Q4 2022 | $2,881 | -100.0% | 14,660 | -73.7% | 0.00% | -71.4% |
| Q3 2022 | $12,548,000 | +88.3% | 55,787 | +5.9% | 0.01% | +40.0% |
| Q2 2022 | $6,665,000 | +1214.6% | 52,679 | +1217.3% | 0.01% | – |
| Q1 2022 | $507,000 | -64.0% | 3,999 | -62.9% | 0.00% | -100.0% |
| Q4 2021 | $1,410,000 | -48.4% | 10,766 | -51.8% | 0.00% | -50.0% |
| Q3 2021 | $2,734,000 | +197.8% | 22,348 | +192.6% | 0.00% | – |
| Q1 2021 | $918,000 | -84.1% | 7,637 | -86.6% | 0.00% | -100.0% |
| Q4 2020 | $5,771,000 | +62.7% | 56,807 | +23.8% | 0.00% | 0.0% |
| Q3 2020 | $3,547,000 | +174.3% | 45,872 | +295.6% | 0.00% | +100.0% |
| Q2 2020 | $1,293,000 | +112.0% | 11,597 | -69.0% | 0.00% | +100.0% |
| Q3 2019 | $610,000 | -57.1% | 37,398 | -47.3% | 0.00% | -50.0% |
| Q2 2019 | $1,421,000 | – | 70,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |